Ushbu ish iqtibos qilgan ishlar

154 ta ish

Ish: Non-Coding RNAs as key regulators of interferon signaling in cancer immunotherapy: mechanistic insights and clinical prospects

1. Long non‐coding <scp>RNA GAS</scp>5 is induced by interferons and plays an antitumor role in esophageal squamous cell carcinoma

   Jianbing Huang, Yuan Li, Zhiliang Lu +8

   Maqola20183 iqtibos

   ABIABI:AkademIndex/openalex/2026.other.224068

2. Interferon-inducible lncRNA IRF1-AS represses esophageal squamous cell carcinoma by promoting interferon response

   Jianbing Huang, Jiagen Li, Yuan Li +11

   Maqola20193 iqtibos

   ABIABI:AkademIndex/openalex/2026.other.224084

3. A novel LncRNA PTH-AS upregulates interferon-related DNA damage resistance signature genes and promotes metastasis in human breast cancer xenografts

   Miho Akimoto, Takao Susa, Noriyuki Okudaira +5

   Maqola20223 iqtibos

   ABIABI:AkademIndex/openalex/2026.other.224136

4. Screening and identification of epithelial-to-mesenchymal transition-related circRNA and miRNA in prostate cancer

   Zhijian Yan, Yiming Xiao, Yiyan Chen +1

   Maqola20193 iqtibos

   ABIABI:AkademIndex/openalex/2026.other.389713

5. Tumor biomarkers for diagnosis, prognosis and targeted therapy

   Yue Zhou, Lei Tao, Jiahao Qiu +7

   Sharh maqola20243 iqtibos

   ABIABI:AkademIndex/openalex/2026.other.443991

6. LncRNA GAS5 enhanced the killing effect of NK cell on liver cancer through regulating miR-544/RUNX3

   Peipei Fang, Luxia Xiang, Weilai Chen +8

   Maqola20193 iqtibos

   ABIABI:AkademIndex/openalex/2026.other.562719

7. Long non-coding RNA GAS5 promotes natural killer cell cytotoxicity against gastric cancer by regulating miR-18a

   Mojieming Wei, Zhuoyu Gu, Lili Zheng +2

   Maqola20203 iqtibos

   ABIABI:AkademIndex/openalex/2026.other.562740

8. Roles of IFN-γ in tumor progression and regression: a review

   Dragica Jorgovanović, Mengjia Song, Liping Wang +1

   Sharh maqola20203 iqtibos

   ABIABI:AkademIndex/openalex/2026.other.816527

9. siRNA Nanoparticle Targeting PD-L1 Activates Tumor Immunity and Abrogates Pancreatic Cancer Growth in Humanized Preclinical Model

   Jae Yun Jung, Hyun Jin Ryu, Seung‐Hwan Lee +9

   Maqola20213 iqtibos

   ABIABI:AkademIndex/openalex/2026.other.816543

10. Non‐coding RNAs in cancer immunotherapy: Predictive biomarkers and targets

    Murad Alahdal, Eyad Elkord

    Sharh maqola20233 iqtibos

    ABIABI:AkademIndex/openalex/2026.other.816564

11. lncRNA PVT1: a novel oncogene in multiple cancers

    Ruiming Li, Xia Wang, Chunming Zhu +1

    Sharh maqola20222 iqtibos

    ABIABI:AkademIndex/openalex/2026.other.091580

12. miR-146a suppresses the sensitivity to interferon-α in hepatocellular carcinoma cells

    Akira Tomokuni, Hidetoshi Eguchi, Yoshito Tomimaru +8

    Maqola20112 iqtibos

    ABIABI:AkademIndex/openalex/2026.other.247234

13. Synergistic Immunoregulation: harnessing CircRNAs and PiRNAs to Amplify PD-1/PD-L1 Inhibition Therapy

    Rui Han, Xiwu Rao, Huiling Zhou +1

    Maqola20242 iqtibos

    ABIABI:AkademIndex/openalex/2026.other.442039

14. Selective targeting of IRF4 by synthetic microRNA-125b-5p mimics induces anti-multiple myeloma activity in vitro and in vivo

    Eugenio Morelli, Emanuela Leone, Maria Eugenia Gallo Cantafio +13

    Maqola20152 iqtibos

    ABIABI:AkademIndex/openalex/2026.other.816460

15. Cutting Edge: Down-Regulation of MHC Class I-Related Chain A on Tumor Cells by IFN-γ-Induced MicroRNA

    Deepak Yadav, Jennifer Ngolab, Rod Seung-Hwan Lim +2

    Maqola20092 iqtibos

    ABIABI:AkademIndex/openalex/2026.other.816461

16. Regulation of Interferon-Stimulated Gene BST2 by a lncRNA Transcribed from a Shared Bidirectional Promoter

    Hiroto Kambara, Lalith Gunawardane, Elizabeth Zebrowski +6

    Maqola20152 iqtibos

    ABIABI:AkademIndex/openalex/2026.other.816463

17. miR‐545 inhibited pancreatic ductal adenocarcinoma growth by targeting RIG‐I

    Bin Song, Weiping Ji, Shiwei Guo +5

    Maqola20142 iqtibos

    ABIABI:AkademIndex/openalex/2026.other.816464

18. BANF1 Is Downregulated by IRF1-Regulated MicroRNA-203 in Cervical Cancer

    Langyong Mao, Yan Zhang, Wenjuan Mo +2

    Maqola20152 iqtibos

    ABIABI:AkademIndex/openalex/2026.other.816465

19. MicroRNA Expression, Survival, and Response to Interferon in Liver Cancer

    Junfang Ji, Jiong Shi, Anuradha Budhu +16

    Maqola20092 iqtibos

    ABIABI:AkademIndex/openalex/2026.other.816468

20. socs7, a target gene of microRNA-145, regulates interferon-β induction through STAT3 nuclear translocation in bladder cancer cells

    Shunsuke Noguchi, Nami Yamada, Minami Kumazaki +4

    Maqola20132 iqtibos

    ABIABI:AkademIndex/openalex/2026.other.816471

21. The association of blood angioregulatory microRNA levels with circulating endothelial cells and angiogenic proteins in patients receiving dacarbazine and interferon

    Pierre L. Triozzi, Susan Achberger, Wayne Aldrich +3

    Maqola20122 iqtibos

    ABIABI:AkademIndex/openalex/2026.other.816475

22. micro<scp>RNA</scp>‐762 promotes breast cancer cell proliferation and invasion by targeting <scp>IRF</scp>7 expression

    Yongping Li, Ruixue Huang, Ling Wang +4

    Maqola20152 iqtibos

    ABIABI:AkademIndex/openalex/2026.other.816477

23. MicroRNA‐18a modulates P53 expression by targeting IRF2 in gastric cancer patients

    Yan‐Jie Chen, Hao Wu, Ji‐Min Zhu +5

    Maqola20152 iqtibos

    ABIABI:AkademIndex/openalex/2026.other.816478

24. IFN-γ-mediated IRF1/miR-29b feedback loop suppresses colorectal cancer cell growth and metastasis by repressing IGF1

    Yuan Li, Chang Zhou, Yanxia Lu +6

    Maqola20152 iqtibos

    ABIABI:AkademIndex/openalex/2026.other.816479

25. MicroRNA-21 Limits In Vivo Immune Response-Mediated Activation of the IL-12/IFN-γ Pathway, Th1 Polarization, and the Severity of Delayed-Type Hypersensitivity

    Thomas X. Lu, Jochen C. Hartner, Eun‐Jin Lim +6

    Maqola20112 iqtibos

    ABIABI:AkademIndex/openalex/2026.other.816480